Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.

Kornstein SG, Pedersen RD, Holland PJ, Nemeroff CB, Rothschild AJ, Thase ME, Trivedi MH, Ninan PT, Keller MB.

J Clin Psychiatry. 2014 Jan;75(1):62-8. doi: 10.4088/JCP.12m07841.

PMID:
24345717
2.

NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome.

Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y, McFann KK, Holland PJ, Fain PR, Dinarello CA, Spritz RA.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2952-6. doi: 10.1073/pnas.1222808110. Epub 2013 Feb 4.

3.

Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent.

Birlea SA, Ahmad FJ, Uddin RM, Ahmad S, Pal SS, Begum R, Laddha NC, Dwivedi M, Shoab Mansuri M, Jin Y, Gowan K, Riccardi SL, Holland PJ, Ben S, Fain PR, Spritz RA.

J Invest Dermatol. 2013 May;133(5):1369-72. doi: 10.1038/jid.2012.501. Epub 2013 Jan 10. No abstract available.

4.

In vitro electroporation of the lower rhombic lip of midgestation mouse embryos.

Holland PJ, George AM, Worrell LT, Landsberg RL.

J Vis Exp. 2012 Aug 3;(66):e3983. doi: 10.3791/3983.

5.

Dopamine receptor-interacting protein 78 acts as a molecular chaperone for CCR5 chemokine receptor signaling complex organization.

Kuang YQ, Charette N, Frazer J, Holland PJ, Attwood KM, Dellaire G, Dupré DJ.

PLoS One. 2012;7(7):e40522. doi: 10.1371/journal.pone.0040522. Epub 2012 Jul 16.

6.

Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC, Luiten RM, Wolkerstorfer A, van der Veen JP, Hartmann A, Eichner S, Schuler G, van Geel N, Lambert J, Kemp EH, Gawkrodger DJ, Weetman AP, Taïeb A, Jouary T, Ezzedine K, Wallace MR, McCormack WT, Picardo M, Leone G, Overbeck A, Silverberg NB, Spritz RA.

Nat Genet. 2012 May 6;44(6):676-80. doi: 10.1038/ng.2272.

7.

Structural reorganization of the interleukin-7 signaling complex.

McElroy CA, Holland PJ, Zhao P, Lim JM, Wells L, Eisenstein E, Walsh ST.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2503-8. doi: 10.1073/pnas.1116582109. Epub 2012 Jan 30.

8.

Biophysical characterization of glycosaminoglycan-IL-7 interactions using SPR.

Zhang F, Liang X, Pu D, George KI, Holland PJ, Walsh ST, Linhardt RJ.

Biochimie. 2012 Jan;94(1):242-9. doi: 10.1016/j.biochi.2011.10.015. Epub 2011 Nov 6.

9.

Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.

Powell RD, Holland PJ, Hollis T, Perrino FW.

J Biol Chem. 2011 Dec 23;286(51):43596-600. doi: 10.1074/jbc.C111.317628. Epub 2011 Nov 7.

10.

5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail.

Barclay Z, Dickson L, Robertson DN, Johnson MS, Holland PJ, Rosie R, Sun L, Fleetwood-Walker S, Lutz EM, Mitchell R.

Biochem J. 2011 Jun 15;436(3):651-60. doi: 10.1042/BJ20101844.

11.

Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

J Invest Dermatol. 2011 Jun;131(6):1308-12. doi: 10.1038/jid.2011.12. Epub 2011 Feb 17.

12.

Common variants in FOXP1 are associated with generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL, Gowan K, Holland PJ, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

Nat Genet. 2010 Jul;42(7):576-8. doi: 10.1038/ng.602. Epub 2010 Jun 6.

13.

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJ, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

N Engl J Med. 2010 May 6;362(18):1686-97. doi: 10.1056/NEJMoa0908547. Epub 2010 Apr 21.

14.

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.

Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A; LEADe Investigators.

Neurology. 2010 Mar 23;74(12):956-64. doi: 10.1212/WNL.0b013e3181d6476a. Epub 2010 Mar 3.

PMID:
20200346
15.
16.

The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.

Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H; LEADe investigators.

Alzheimers Dement. 2008 Mar;4(2):145-53. doi: 10.1016/j.jalz.2008.02.001.

PMID:
18631958
17.

Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF).

Johnson MS, Robertson DN, Holland PJ, Lutz EM, Mitchell R.

Cell Signal. 2006 Oct;18(10):1793-800. Epub 2006 Mar 20.

PMID:
16545942
18.

Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.

Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.

Mol Cell Neurosci. 2006 Feb;31(2):193-209. Epub 2005 Oct 14.

PMID:
16226889
19.

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness.

Sheikh JI, Cassidy EL, Doraiswamy PM, Salomon RM, Hornig M, Holland PJ, Mandel FS, Clary CM, Burt T.

J Am Geriatr Soc. 2004 Jan;52(1):86-92. Erratum in: J Am Geriatr Soc. 2004 Jul;52(7):1228.

PMID:
14687320
20.

Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor.

Robertson DN, Johnson MS, Moggach LO, Holland PJ, Lutz EM, Mitchell R.

Mol Pharmacol. 2003 Nov;64(5):1239-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk